These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16960898)

  • 1. A new enzyme-linked chemiluminescent immunosorbent digoxin assay is virtually free from interference of spironolactone, potassium canrenoate, and their common metabolite canrenone.
    Dasgupta A; Kang E; Datta P
    J Clin Lab Anal; 2006; 20(5):204-8. PubMed ID: 16960898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new turbidometric digoxin immunoassay on the ADVIA 1650 analyzer is free from interference by spironolactone, potassium canrenoate, and their common metabolite canrenone.
    Datta P; Dasgupta A
    Ther Drug Monit; 2003 Aug; 25(4):478-82. PubMed ID: 12883233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of spironolactone, potassium canrenoate and their common metabolite canrenone on serum digoxin measurement by digoxin III, a new digoxin immunoassay.
    Dasgupta A; Tso G; Wells A
    Ther Drug Monit; 2008 Dec; 30(6):744-7. PubMed ID: 18824952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bidirectional (positive/negative) interference of spironolactone, canrenone, and potassium canrenoate on serum digoxin measurement: elimination of interference by measuring free digoxin or using a chemiluminescent assay for digoxin.
    Dasgupta A; Saffer H; Wells A; Datta P
    J Clin Lab Anal; 2002; 16(4):172-7. PubMed ID: 12112389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, potassium canrenoate, and their common metabolite canrenone.
    DeFrance A; Armbruster D; Petty D; Cooper KC; Dasgupta A
    Ther Drug Monit; 2011 Feb; 33(1):128-31. PubMed ID: 21079546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically insignificant negative interferences of spironolactone, potassium canrenoate, and their common metabolite canrenone in new dimension vista LOCI digoxin immunoassay.
    Dasgupta A; Johnson MJ; Sengupta TK
    J Clin Lab Anal; 2012 May; 26(3):143-7. PubMed ID: 22628228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of spironolactone, potassium canrenoate, and their common metabolite canrenone on Dimension Vista Digoxin Assay.
    Dasgupta A; Johnson MJ
    J Clin Lab Anal; 2010; 24(6):413-7. PubMed ID: 21089173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New enzyme-linked chemiluminescent immunosorbent digoxin assay is free from interference of Chinese medicine DanShen.
    Dasgupta A; Kang E; Olsen M; Actor JK; Datta P
    Ther Drug Monit; 2006 Dec; 28(6):775-8. PubMed ID: 17164693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference of Asian, American, and Indian (Ashwagandha) ginsengs in serum digoxin measurements by a fluorescence polarization immunoassay can be minimized by using a new enzyme-linked chemiluminescent immunosorbent or turbidimetric assay.
    Dasgupta A; Kang E; Olsen M; Actor JK; Datta P
    Arch Pathol Lab Med; 2007 Apr; 131(4):619-21. PubMed ID: 17425395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New enzyme-linked immunosorbent digoxin assay on the ADVIA IMS 800i system is virtually free from interference of endogenous digoxin-like immunoreactive factors.
    Dasgupta A; Kang E; Datta P
    Ther Drug Monit; 2005 Apr; 27(2):139-43. PubMed ID: 15795642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new enzyme-linked immunosorbent digoxin assay on the ADVIA Integrated Modular System is virtually free from oleander interference.
    Dasgupta A; Kang E; Datta P
    Ther Drug Monit; 2006 Apr; 28(2):282-5. PubMed ID: 16628146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids.
    Steimer W; Müller C; Eber B
    Clin Chem; 2002 Mar; 48(3):507-16. PubMed ID: 11861441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reassessment of cross-reactivity of spironolactone metabolites with four digoxin immunoassays.
    Pleasants RA; Williams DM; Porter RS; Gadsden RH
    Ther Drug Monit; 1989; 11(2):200-4. PubMed ID: 2655203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference of endogenous digoxin-like immunoreactive factors in serum digoxin measurement is minimized in a new turbidimetric digoxin immunoassay on ADVIA 1650 analyzer.
    Datta P; Dasgupta A
    Ther Drug Monit; 2004 Feb; 26(1):85-9. PubMed ID: 14749555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid detection of oleander poisoning using digoxin immunoassays: comparison of five assays.
    Dasgupta A; Datta P
    Ther Drug Monit; 2004 Dec; 26(6):658-63. PubMed ID: 15570191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interference between eplerenone and digoxin in fluorescence polarization immunoassay, microparticle enzyme immunoassay, and affinity column-mediated immunoassay.
    Yamada T; Suzuki K; Iguchi K; Kanada Y; Kato R; Ijiri Y; Nishihara M; Murakami S; Hayashi T; Tamai H; Tanaka K
    Ther Drug Monit; 2010 Dec; 32(6):774-7. PubMed ID: 20625353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spironolactone metabolite causes falsely increased progesterone in the Abbott Architect immunoassay.
    Sarpong KAN; Hee Kim S; McCartney CR; Wiencek JR; Bazydlo LAL
    Clin Biochem; 2024 Apr; 126():110747. PubMed ID: 38484829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of spironolactone and its metabolite canrenone on serum digoxin assays.
    Foukaridis GN
    Ther Drug Monit; 1990 Jan; 12(1):82-4. PubMed ID: 2305425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of oral spironolactone and intravenous canrenoate-K on the digoxin radioimmunoassay.
    Lichey J; Schröder R; Rietbrock N
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):557-9. PubMed ID: 598949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canrenone--the principal active metabolite of spironolactone?
    Ramsay LE; Shelton JR; Wilkinson D; Tidd MJ
    Br J Clin Pharmacol; 1976 Aug; 3(4):607-12. PubMed ID: 22216502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.